Biora Therapeutics Future Growth
Future criteria checks 2/6
Biora Therapeutics is forecast to grow earnings and revenue by 0.4% and 57.2% per annum respectively while EPS is expected to grow by 46.2% per annum.
Key information
0.4%
Earnings growth rate
46.2%
EPS growth rate
| Biotechs earnings growth | 23.2% |
| Revenue growth rate | 57.2% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 09 Apr 2024 |
Recent future growth updates
Recent updates
Biora Therapeutics granted patent for oral delivery of GLP-1 receptor agonists
Sep 13Biora Therapeutics: Checking In On The Transformation
Aug 17Biora rallies 30%, highest since November on data for drug delivery device
Aug 10Progenity: Analyzing The Huge Paradigm Shift
Dec 20Progenity: Transformation Raises Questions
Oct 03Progenity on a roller coaster ride since strategic transformation announcement
Jun 09Progenity presents new study data for preeclampsia rule-out Test
Apr 30Earnings Release: Here's Why Analysts Cut Their Progenity, Inc. (NASDAQ:PROG) Price Target To US$8.00
Mar 20
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 6 | -97 | N/A | N/A | 1 |
| 12/31/2025 | 3 | -77 | N/A | N/A | 2 |
| 12/31/2024 | 0 | -68 | N/A | N/A | 2 |
| 12/31/2023 | 0 | -124 | -49 | -48 | N/A |
| 9/30/2023 | 0 | -122 | -46 | -46 | N/A |
| 6/30/2023 | 0 | -64 | -45 | -45 | N/A |
| 3/31/2023 | 0 | -52 | -53 | -53 | N/A |
| 12/31/2022 | 0 | -49 | -65 | -64 | N/A |
| 9/30/2022 | 1 | -118 | -94 | -93 | N/A |
| 6/30/2022 | 1 | -140 | -127 | -127 | N/A |
| 3/31/2022 | 1 | -176 | -144 | -143 | N/A |
| 12/31/2021 | 1 | -179 | -168 | -167 | N/A |
| 9/30/2021 | 1 | -146 | -201 | -198 | N/A |
| 6/30/2021 | 1 | -142 | -211 | -207 | N/A |
| 3/31/2021 | -16 | -106 | -187 | -183 | N/A |
| 12/31/2020 | 0 | -105 | -170 | -166 | N/A |
| 9/30/2020 | 21 | -142 | -143 | -141 | N/A |
| 6/30/2020 | 39 | -207 | -114 | -112 | N/A |
| 3/31/2020 | 113 | -218 | -119 | -115 | N/A |
| 12/31/2019 | 144 | -229 | -110 | -106 | N/A |
| 9/30/2019 | 120 | -211 | -96 | -92 | N/A |
| 12/31/2018 | 128 | -129 | -70 | -65 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BIOR is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: BIOR is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: BIOR is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: BIOR's revenue (57.2% per year) is forecast to grow faster than the US market (8.2% per year).
High Growth Revenue: BIOR's revenue (57.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BIOR's Return on Equity is forecast to be high in 3 years time